Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Gegen Qinlian Decoction for Ulcerative Colitis (Dampness-heat Syndrome)
NCT04057547Phase 1Unknown
- Sponsor
- Xiyuan Hospital
- Start
- Apr 2019
- Primary completion
- Jul 2019
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Phase 1, randomised trial of modified Gegen Qinlian decoction in ulcerative colitis (UC) (2 arms), sponsored by Xiyuan Hospital. Primary endpoints: Improved Mayo scale at 4 weeks and Clinical Global Impression of severity Scale at 4 weeks. Status: unknown.
02
Drugs
modified Gegen Qinlian decoction
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT04057547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04057547.